Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Taiwan ETF (EWT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

iShares MSCI Taiwan ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Taiwan ETF vs Health Care Select Sector SPDR Fund — how do they compare? iShares MSCI Taiwan ETF trades at $113.95 (market cap $12.74B), while Health Care Select Sector SPDR Fund trades at $170.62 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 3.4× iShares MSCI Taiwan ETF's market cap, and Health Care Select Sector SPDR Fund is more actively traded (11,121,431 versus 8,470,920). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Taiwan ETF for 52 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

EWTXLV
Market Cap
$12.74B$43.48B
Volume
8,470,92011,121,431
Sector
Broad Market / Factor—
52-Week High
$118.00$175.68
52-Week Low
$60.03$141.95
Typical Hold Time
52 Days100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Taiwan ETF

EWT trades at $114.01, down 1.92% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF maintains strong exposure to Taiwan's semiconductor sector, particularly TSMC, which represents 22.5% of its portfolio. Recent news highlights Taiwan's strategic importance in AI chip manufacturing and ongoing US-Taiwan economic cooperation, with Taiwanese companies planning $20 billion in US investments driven by AI demand (Reuters, 2026-09-02).

The outlook remains positive given Taiwan's central role in AI semiconductor supply chains, though geopolitical tensions with China present significant risks. Analyst sentiment is generally bullish with institutional investors increasing positions, including Bank of America's 22.4% stake increase in Q2 2026. Key support levels at $110-$112 provide downside protection while resistance sits at $115-$117.

Health Care Select Sector SPDR Fund

XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.

The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWT
93% Buy7% Sell
Avg holding period · 52 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

About iShares MSCI Taiwan ETF

EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.

Read more on EWT →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →